No. UK weight-loss clinics must not advertise prescription-only medicines or prescription-only treatments to the public. They may promote a weight-management service or consultation, but the advert, imagery, landing page and wider user journey must not be likely to lead someone towards a particular prescription medicine. Public content should focus on the condition, the clinical assessment and the service, with accurate claims and a genuine range of possible next steps.
That distinction matters because regulators look beyond a single headline. A paid advert can appear neutral and still breach the rules if its button, quiz, filter or landing page guides the visitor to a prescription-only medicine. Recent MHRA actions and an ASA ruling published on 29 July 2026 show that this remains an active enforcement area.
This article is practical marketing guidance, not legal, medical or regulatory advice. Clinics, pharmacies and prescribers should have current campaigns reviewed by an appropriately qualified adviser before publication.
The boundary is service promotion, not medicine promotion
The Human Medicines Regulations and CAP Code prohibit advertising prescription-only medicines to the public. CAP Code rule 12.12 applies to prescription-only medicines and prescription-only medical treatments. The restriction is not confined to naming a brand. Regulators may consider wording, images and the path a consumer is invited to follow.
The MHRA says a treatment-service provider may promote the service or consultation it offers. Public website entry points should focus on the medical condition and the service, rather than named prescription-only medicines. This creates a workable marketing route, but it is narrower than simply removing a product name from otherwise promotional copy.
| Public-facing element | Safer focus | Higher-risk direction |
|---|---|---|
| Advert headline | Clinical weight-management assessment | A named medicine, medicine class or prescription treatment |
| Visual | Consultation, support process or neutral clinic imagery | Injection pens, medicine packaging or product-shaped silhouettes |
| Call to action | Learn about the service or book an assessment | Choose a medicine, check availability or join a product waiting list |
| Landing page | Condition, eligibility, clinical process and possible pathways | A prominent product, price comparison or route to request one treatment |
| Proof | Verifiable service standards and balanced patient experience | Guaranteed loss, universal suitability or unsupported outcome claims |
This is a decision framework, not a list of automatically approved phrases. Context changes how a claim is understood. The safest question is not “Did we avoid the brand name?” but “Would an ordinary visitor understand this campaign as encouraging use of a prescription-only medicine?”
Regulators can assess the complete user journey
In the July 2026 Bolt Healthcare ruling, the ASA considered both the Facebook adverts and the pages reached after clicking. One advert referred to “prescription treatments”, but the assessment went further. The linked journey passed through filtering or age-gate steps to pages referencing prescription-only medicines. The ASA concluded that the ads promoted those medicines to the public.
An age gate, eligibility quiz or extra click does not necessarily separate an advert from the destination. If the steps form a guided route to a prescription medicine, the whole journey may be considered together. Review paid social, search ads, affiliate pages, organic posts, email campaigns and public website paths as connected parts of one system.
Affiliates and agencies need the same controls. A clinic can still face risk when a third party uses unapproved copy, an apparently independent comparison page or a promotional redirect. Keep an inventory of live campaigns, approved landing pages and partner domains. Require sign-off for wording and destinations, then check that the published version matches what was approved.
What a weight-loss clinic can promote responsibly
A useful public page can explain what the service does without promising a particular prescription. Start with the patient decision: who the service is designed for, what happens during assessment, who makes clinical decisions, what monitoring and support are included, what the service costs and what alternative outcomes may follow.
Make clinical independence visible. A visitor should understand that completing a form or paying for a consultation does not guarantee a prescription. Explain that suitability depends on individual assessment and that the clinician may recommend a different approach or no medicine at all. Do not imply that an automated score is a diagnosis or prescribing decision.
Deeper educational pages require particular care. MHRA guidance recognises that a consumer who chooses to read further may encounter non-promotional information about specific medicines when it appears within a fair overview of treatment options. That does not turn a product page into a safe public landing page. Information should be balanced, factual and separated from promotional routes, with the complete architecture reviewed for its likely effect.
Keep outcome claims, testimonials and urgency under control
Removing medicine names does not solve every advertising risk. Objective weight-loss or health claims still need appropriate evidence. CAP says testimonials do not provide substantiation on their own, so a dramatic patient story cannot support a claim the clinic could not make directly.
Avoid guaranteed results, “risk-free” language and suggestions that the service suits everyone. State important limitations in the main presentation rather than hiding them in a footer. Good medical practice also requires doctors' public communications to be accurate, not misleading, and not to minimise risks or exploit a person's vulnerability or lack of medical knowledge.
Pressure tactics deserve special scrutiny. Countdown timers, “system error” prices, short booking windows and scarcity claims can encourage hurried decisions about healthcare. Use transparent fees and genuine capacity information, but give prospective patients enough space to consider whether assessment is appropriate.
Build search visibility around patient questions and the service
Search optimisation does not require product-led copy. A clinic can earn relevant visibility through clear pages about its weight-management service, the assessment pathway, practitioner credentials, ongoing support, locations, fees and common pre-consultation questions. The content should help people decide whether the service may be relevant, not steer them towards a preselected prescription.
Keep the same facts consistent across the website, Google Business Profile and trusted directories. Describe the real service and location without adding product keywords to the business name. When commissioning content, provide the writer with the approved service boundary, current clinical process and a claims register so search language does not outrun what the clinic can support.
For clinics that need this regulatory care carried into their site structure and search content, Kay & Co.'s doctor-led SEO service for private doctors connects useful patient information with accountable digital visibility.
Use a documented pre-publication workflow
- Map the audience. Confirm whether the material is public-facing or genuinely restricted to healthcare professionals. Do not assume a trade label makes a public page restricted.
- Trace every click. Review the advert, expanded copy, quiz, age gate, landing page, navigation, follow-up email and retargeting sequence.
- Flag product cues. Look for medicine names, medicine classes, “injection” language, packaging, device imagery, product prices and availability messages.
- Test the service focus. The page should explain the condition, assessment and provider, with more than one possible clinical outcome.
- Check every objective claim. Record the evidence, approved wording, important qualifications and review date.
- Review testimonials and urgency. Confirm permission and authenticity, remove unsupported implied claims and challenge tactics that could rush a healthcare decision.
- Assign clinical and regulatory sign-off. Name the accountable reviewer, keep the approved version and recheck it after platform or landing-page changes.
A one-page claims register is often more useful than a long policy nobody opens. Record the exact claim, where it appears, the supporting evidence, required qualification, owner and next review date. Marketing teams can then reuse approved language without rebuilding the risk assessment for every channel.
Measure assessment quality, not product demand
A compliant campaign should not be optimised towards requests for a named medicine. Measure relevant service-page visits, completed suitability forms, booked assessments, attendance and the proportion of enquiries appropriate for clinical review. Keep prescribing decisions out of marketing targets.
Monitor the quality of the journey as well as conversion. A rising rate of people arriving with a fixed expectation of one product can indicate that copy, affiliates or ads are implying more than the clinic intended. Review search terms, ad comments and enquiry notes for that signal, using only the minimum data needed and keeping health information out of routine marketing analytics where possible.
The commercial lesson is straightforward. Responsible constraints do not prevent useful marketing. They force the clinic to compete on the quality of its assessment, information, support and patient experience, which are stronger long-term differentiators than a product-led advert.
Frequently asked questions
A clinic must not advertise prescription-only medicines or prescription-only treatments to the public. That restriction applies across paid search, social ads, organic social content and public website journeys. A clinic can promote its weight-management service or consultation, but the wording, imagery and linked journey must not be likely to lead the public to request a prescription-only medicine.
MHRA guidance allows carefully controlled, non-promotional information about specific medicines on deeper pages when it sits within a fair overview of treatment options. That is not permission to feature a medicine on a public landing page or guide visitors towards it through an advert, filter, quiz or age gate. The complete journey and context need specialist review.
A clinic can promote the service or consultation it genuinely provides. Public-facing content can explain the condition, eligibility process, clinical assessment, practitioner credentials, support model, fees for the service and how to enquire, provided the presentation remains accurate, balanced and does not promote a prescription-only medicine.
